Logo image of ALTHE.PA

THERACLION (ALTHE.PA) Stock Fundamental Analysis

EPA:ALTHE - FR0010120402 - Common Stock

0.714 EUR
-0.03 (-3.51%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

1

ALTHE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 57 industry peers in the Health Care Equipment & Supplies industry. ALTHE may be in some trouble as it scores bad on both profitability and health. ALTHE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALTHE had negative earnings in the past year.
In the past year ALTHE has reported a negative cash flow from operations.
ALTHE had negative earnings in each of the past 5 years.
In the past 5 years ALTHE always reported negative operating cash flow.
ALTHE.PA Yearly Net Income VS EBIT VS OCF VS FCFALTHE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

ALTHE's Return On Assets of -50.21% is on the low side compared to the rest of the industry. ALTHE is outperformed by 85.96% of its industry peers.
Industry RankSector Rank
ROA -50.21%
ROE N/A
ROIC N/A
ROA(3y)-35.17%
ROA(5y)-34.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTHE.PA Yearly ROA, ROE, ROICALTHE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M 4M 5M

1.3 Margins

ALTHE has a Gross Margin of 42.86%. This is in the lower half of the industry: ALTHE underperforms 70.18% of its industry peers.
ALTHE's Gross Margin has been stable in the last couple of years.
ALTHE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.68%
GM growth 5Y0.37%
ALTHE.PA Yearly Profit, Operating, Gross MarginsALTHE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

2

2. Health

2.1 Basic Checks

ALTHE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALTHE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALTHE has been increased compared to 5 years ago.
The debt/assets ratio for ALTHE is higher compared to a year ago.
ALTHE.PA Yearly Shares OutstandingALTHE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALTHE.PA Yearly Total Debt VS Total AssetsALTHE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -0.36, we must say that ALTHE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.36, ALTHE is doing worse than 77.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.36
ROIC/WACCN/A
WACC7.69%
ALTHE.PA Yearly LT Debt VS Equity VS FCFALTHE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M -8M

2.3 Liquidity

ALTHE has a Current Ratio of 2.20. This indicates that ALTHE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALTHE (2.20) is better than 64.91% of its industry peers.
ALTHE has a Quick Ratio of 1.64. This is a normal value and indicates that ALTHE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.64, ALTHE is in the better half of the industry, outperforming 71.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.64
ALTHE.PA Yearly Current Assets VS Current LiabilitesALTHE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ALTHE have decreased strongly by -53.33% in the last year.
The Revenue for ALTHE has decreased by -54.44% in the past year. This is quite bad
Measured over the past years, ALTHE shows a very negative growth in Revenue. The Revenue has been decreasing by -21.49% on average per year.
EPS 1Y (TTM)-53.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-129.76%
Revenue 1Y (TTM)-54.44%
Revenue growth 3Y-17.55%
Revenue growth 5Y-21.49%
Sales Q2Q%27.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALTHE.PA Yearly Revenue VS EstimatesALTHE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTHE.PA Yearly EPS VS EstimatesALTHE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2024 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALTHE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALTHE.PA Price Earnings VS Forward Price EarningsALTHE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALTHE.PA Per share dataALTHE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALTHE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

THERACLION

EPA:ALTHE (9/5/2025, 7:00:00 PM)

0.714

-0.03 (-3.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)10-29 2025-10-29
Inst Owners1.35%
Inst Owner ChangeN/A
Ins Owners19%
Ins Owner ChangeN/A
Market Cap33.60M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 40.47
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.02
BVpS0
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.21%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.86%
FCFM N/A
ROA(3y)-35.17%
ROA(5y)-34.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.68%
GM growth 5Y0.37%
F-Score1
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.38%
Cap/Sales 12.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 1.64
Altman-Z -0.36
F-Score1
WACC7.69%
ROIC/WACCN/A
Cap/Depr(3y)103.96%
Cap/Depr(5y)101.1%
Cap/Sales(3y)14.86%
Cap/Sales(5y)14.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-129.76%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-54.44%
Revenue growth 3Y-17.55%
Revenue growth 5Y-21.49%
Sales Q2Q%27.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-116.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.16%
OCF growth 3YN/A
OCF growth 5YN/A